Sensorineural hear-loss in patients with rheumatoid arthritis

Abstract

Objectives: The aim of this study was to evaluate the rate and type of the hearing loss in patients with rheuma­toid arthritis (RA); and to analyze whether these hearing loss rates were different from control group or not. Materials and methods: The study included 50 RA pa­tients and 34 healthy control subjects. All two groups un­derwent, pure tone audiometric test between 250-8.000 Hz frequencies; stapes reflex test and otoacoustic emis­sions. Results: The mean ages were 36, 88 ± 8, 81 years in RA cases and 35, 58 ± 8, 19 years in control group. The mean disease duration was 4.72 (range 2-21) years in patients with RA. Hearing loss was detected in 10 (20%) of the RA patients and 3 (8.8%) of the control group. The difference between the groups was not statistically signifi­cant in terms of hearing loss (p=0,139). The sensorineural hearing loss was the most commonly detected hearing loss type. The distribution of this type of hearing loss was 14% in RA and 8.8% in control group. Hearing loss was present in 6 (85.7%) of the seven RA patients whose du­ration of the disease was more than 10 years. Conclusion: There was not found significant difference between RA and control group with respect to hearing loss. In RA cases, the degree of hearing loss was increas­ing with the duration of the diseases.

Keywords

• Rheumatoid arthritis, disease duration, hear­ing loss.

Romatoid artritli hastalarda sensörinöral işitme kaybı

Abstract

Amaç: Romatoid artrit (RA)\'li hastalarda işitme kaybı ora­nını, tipini ve mevcut kaybın kontrol grubuna göre farklı olup olmadığını araştırmak. Gereç ve yöntem: Çalışmaya 50 RA hastası ve 34 sağ­lıklı kontrol grubu alındı. Her iki gruptakilere; 250-8.000 Hz frekanslar arasında pür tone odyometri, stapes reflek­si ve Oto Akustik Emisyon testi yapıldı. Bulgular: Olguların yaş ortalaması RA\'lı hastalarda 36,88 ± 8,81 yıl ve kontrol grubunda 35,58 ± 8,19 yıl olarak bulundu. Ortalama hastalık süresi RA\'da 4,72 (0-21) yıl bulundu. RA\'lı hastaların 10\' unda (%20) ve kontrol gru­bunun 3\' ünde (%8,8) işitme kaybı saptandı. İşitme kaybı açısından gruplar arasında istatistiksel olarak anlamlı bir fark bulunmadı (p=0,139). Romatoid artritli hastalarda %14 ve kontrol grubundakilerde %8,8 olmak üzere her iki grupta da en sık sensörinöral tip işitme kaybı (SNİK) bulundu. Hastalık süresi 10 yıldan fazla olan yedi RA\'lı hastanın 6\'sında (%85.7) işitme kaybı mevcuttu. Sonuç: Romatoid artrit ve kontrol grubu arasında işitme kaybı açısından anlamlı fark bulunmadı. RA\'lı hastalarda hastalık süresi uzadıkça işitme kaybı görülme oranı art­maktadır.

Keywords

• Romatoid artrit, hastalık süresi, işit­me kaybı

References

1. Takatsu M, Higaki M, Kinoshita H, Mizushima Y, Koizuka I. Ear involvement in patients with rheumatoid arthritis. Otol Neurotol 2005; 26(6):755-1.
2. Rigual NR. Otolaryngologic manifestations of rheumatoid arthritis. Ear Nose Throat J 1987; 66(1):18-22.
3. Coletti V, Fiorino FG, Bruni L, Biasi D. Middle ear me- chanics in subjects with rheumatoid arthritis. Audiology 1997;36(2):136-46.
4. Frade C, Martin C. Diagnostic value of the multi-frequency tympanometry in active rheumatoid arthritis. Auris Nasus Larynx 1998; 25(2):131-6.
5. Ozcan M, Karakus MF, Gunduz OH, Tuncel U, Sahin H. Hearing loss and middle ear involvement in rheumatoid ar- thritis. Rheumatol Int 2002; 22(1):16-9.
6. Reiter D, Konkle DF, Myers AR, Schimmer B, Sugar JO. Middle ear immittance in rheumatoid arthritis. Arch Oto- laryngol 1980;106(1):114-7.
7. Elwany S, El Garf A, Kamel T. Hearing and middle ear func- tion in rheumatoid arthritis. J Rheumatol 1986;13:878-81.
8. Kakani RS, Mehra YN, Deodhar SD, Kakani RS, Mehra YN. Audiovestibular functions in rheumatoid arthritis. J Otolar- yngol 1990;19(1):100-2.

9. Jung TT, Rhee C-K, Lee C, Park YS, Choi DC. Ototoxicity of salicylate, nonsteroidal anti inflammatory drugs and qui- nine. Otolaryngol Clin North Am 1993;26(1):791-812.
10. Marioni G, Perin N, Tregnaghi A, Bellemo B, Staffieri A, de Filippis C. Progressive bilateral sensorineural hearing loss probably induced by chronic cyclosporin. A treatment af- ter renal transplantation for focal glomerulosclerosis. Acta Oto-Laryngol 2004; 124(5):603-7.
11. Toone E, Hayden D, Ellman H. Ototoxicity of chloroquine. Arthritis Rheum 1965; 8(4): 475-6.
12. Casellini C, Citera G, RosemVet M, Ruggeri S, Saviotti A, Maldonado Cocco JA. Audiovestibular disorders in patients with ankylosing spondylitis. J Clin Rheumatol 2005;11(1):81-5.
13. Gussen R. Atypical ossicle joint lesions in rheumatoid ar- thritis with sicca syndrome (Sjogren syndrome). Arch Oto- laryngol 1977; 103(2):284-6.
14. Heyworth T, Liyanage SP: A pilot survey of hearing loss in patient with rheumatoid arthritis. Scand J Rheumatol 1972;1(1):81-3.
15. Kastanioudakis I, Skevas A, Danielidis V, Tsiakou E, Drosos AA, Moustopoulos MH. Inner ear involvement in rheuma- toid arthritis: a prospective clinical study. J Laryngol Otol 1995;109(6):713-8.
16. Magaro M, Zoli A, Altomonte L, et al. Sensorineural hear- ing loss in rheumatoid arthritis. Clin Exp Rheumatol 1990; 8(7):487-90.
17. Öztürk A, Yalçın Ş, Kaygusuz İ, Şahin S, Gök Ü, Karlıdağ T, Ardıçoğlu Ö. High-Frequency Hearing Loss and Middle Ear Involvement in Rheumatoid Arthritis. Am J Otolaryn- gol 2004; 25(3): 411-7.
18. Dikici O, Muluk NB, Tosun AK, Ünlüsoy I. Subjective au- diological tests and transient evoked otoacoustic emissions in patients with rheumatoid arthritis: analysis of the factors aVecting hearing levels. Eur Arch Otorhinolaryngol 2009; 266(12): 1719-26.
19. Robinette M Clinical observations with transient otoacous- tic emissions with adults. Semin Hear 1992; 13(1):23-36.
20. Bonfils P, Bertrand Y, Uziel A. Evoked otoacoustic emis- sions: normative data and presbyacusis. Audiology 1988;27(1):27-35.
21. Desai A, Reed D, Cheyne A Richards S, Prasher D. Absence of otoacoustic emissions in subjects with normal audio- metric thresholds implies exposure to noise. Noise Health 1999;1(1):58-65.
22. Murdin L, Patel S, Walmsley J, Yeoh HL. Hearing difficul- ties are common in patients with rheumatoid arthritis. Clin Rheumatol 2008; 27: 637-40.
23. İkiz AO, Unsal E, Kirkim G, Erdağ TK, Güneri EA. Hear- ing loss and middle ear involvement in patients with juve- nil idiopathic arthritis. Int J Pediatric Otorhinolaryng 2007; 71(8):1079-85.
24. Copeman WSC: Rheumatoid otoarthritis. Br Med J 1963;2(12):1526-1527.
25. Goodwill CJ, Lord IJ, Jones RPK. Hearing in rheumatoid arthritis. Ann Rheum 1972; 31(2):170-3.
26. Gür A, Nas K, Çevik R, Erdoğan F, Denli A. The quality of life status of patients with rheumatoid arthritis and osteoar- thritis. Dicle Tip Dergisi 2000; 1(1): 41-6.